Lucintel’s latest market report analyzed that exosome research provides attractive opportunities in the academic & research institute, pharmaceutical & biotechnology companies, and hospital & clinical testing laboratory markets. The exosome research market is expected to reach $1.16 billion by 2028 with a CAGR of 33.6%. In this market, kits & reagents is the largest segment by product & service, whereas academic & research institutes is largest by end use industry.
Download Brochure of this report by clicking on https://www.lucintel.com/exosome-research-market.aspx
Based on product & service, the exosome research market is segmented into kits & reagents, instruments, and services. The kits & reagents segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to increasing number of cancer patients, growing need for cell-free therapies to treat variety of diseases, and rising funds for life sciences research.
Browse in-depth TOC on “Exosome Research Market”
100 – Figures/Tables
150 – Pages
The Exosome Research Market is marked by the presence of several big and small players. Some of the prominent players offering exosome research include Thermo Fisher Scientific, Bio-Techne Corporation, QIAGEN, System Biosciences, Miltenyi Biotec, NanoSomiX, NorgenBiotek Corp., AMS Biotechnology, and Lonza.
Request Sample Report:
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link firstname.lastname@example.org.
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Dallas, Texas, USA